198 related articles for article (PubMed ID: 15086394)
1. Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
Ferry BL; Misbah SA; Stephens P; Sherrell Z; Lythgoe H; Bateman E; Banner C; Jones J; Groome N; Chapel HM
Clin Exp Immunol; 2004 May; 136(2):297-303. PubMed ID: 15086394
[TBL] [Abstract][Full Text] [Related]
2. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.
Roggelin L; Vinnemeier CD; Fischer-Herr J; Johnson-Weaver BT; Rolling T; Burchard GD; Staats HF; Cramer JP
Vaccine; 2015 Aug; 33(33):4141-5. PubMed ID: 26144902
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.
Evans C; Bateman E; Steven R; Ponsford M; Cullinane A; Shenton C; Duthie G; Conlon C; Jolles S; Huissoon AP; Longhurst HJ; Rahman T; Scott C; Wallis G; Harding S; Parker AR; Ferry BL
Clin Exp Immunol; 2018 Jun; 192(3):292-301. PubMed ID: 29377063
[TBL] [Abstract][Full Text] [Related]
4. Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide.
Staats HF; Kirwan SM; Whisnant CC; Stephenson JL; Wagener DK; Majumder PP
Clin Vaccine Immunol; 2010 Mar; 17(3):412-9. PubMed ID: 20107010
[TBL] [Abstract][Full Text] [Related]
5. Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-
Schaballie H; Bosch B; Schrijvers R; Proesmans M; De Boeck K; Boon MN; Vermeulen F; Lorent N; Dillaerts D; Frans G; Moens L; Derdelinckx I; Peetermans W; Kantsø B; Jørgensen CS; Emonds MP; Bossuyt X; Meyts I
Front Immunol; 2017; 8():546. PubMed ID: 28553290
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine.
Sabitha P; Prabha Adhikari MR; Chowdary A; Prabhu M; Soofi M; Shetty M; Kamath A; Lokaranjan SS; Bangera SS
Indian J Med Sci; 2004 Apr; 58(4):141-9. PubMed ID: 15122049
[TBL] [Abstract][Full Text] [Related]
7. An ELISA method in the diagnosis of typhoid fever.
Vitale G; Librizzi R; Mocciaro C; Friscia I; Blandino E; Usticano V; Mansueto S; Di Fiore M; Reina G; Gambino G
J Clin Lab Immunol; 1990 Apr; 31(4):195-9. PubMed ID: 1967064
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine].
Wang ZG; Zhou WZ; Shi J
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Feb; 18(1):26-9. PubMed ID: 9812477
[TBL] [Abstract][Full Text] [Related]
9. Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti-Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections.
Bucciol G; Schaballie H; Schrijvers R; Bosch B; Proesmans M; De Boeck K; Boon M; Vermeulen F; Lorent N; Dillaerts D; Kantsø B; Jørgensen CS; Emonds MP; Bossuyt X; Moens L; Meyts I
J Clin Immunol; 2020 Jan; 40(1):105-113. PubMed ID: 31705452
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT).
Lee EY; Park JY; Kim DR; Song M; Sahastrabuddhe S; Kim H; Chon Y; Yang JS
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008171. PubMed ID: 32203521
[TBL] [Abstract][Full Text] [Related]
11. Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
Jang MS; Sahastrabuddhe S; Yun CH; Han SH; Yang JS
Microb Pathog; 2016 Aug; 97():19-26. PubMed ID: 27216239
[TBL] [Abstract][Full Text] [Related]
12. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever.
Salazar-González RM; Maldonado-Bernal C; Ramírez-Cruz NE; Rios-Sarabia N; Beltrán-Nava J; Castañón-González J; Castillo-Torres N; Palma-Aguirre JA; Carrera-Camargo M; López-Macías C; Isibasi A
Immunol Lett; 2004 May; 93(2-3):115-22. PubMed ID: 15158606
[TBL] [Abstract][Full Text] [Related]
13. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.
Muhsen K; Pasetti MF; Reymann MK; Graham DY; Levine MM
J Infect Dis; 2014 May; 209(9):1452-8. PubMed ID: 24273182
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers.
Losonsky GA; Ferreccio C; Kotloff KL; Kaintuck S; Robbins JB; Levine MM
J Clin Microbiol; 1987 Dec; 25(12):2266-9. PubMed ID: 3429619
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
Black R; Levine MM; Young C; Rooney J; Levine S; Clements ML; O'Donnell S; Hugues T; Germanier R
Dev Biol Stand; 1983; 53():9-14. PubMed ID: 6307787
[TBL] [Abstract][Full Text] [Related]
17. Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination.
Vadrevu KM; Raju D; Rani S; Reddy S; Sarangi V; Ella R; Javvaji B; Mahantshetty NS; Battu S; Levine MM
Vaccine; 2021 Oct; 39(45):6682-6690. PubMed ID: 34625288
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
Chau PY; Tsang RS
Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
[TBL] [Abstract][Full Text] [Related]
19. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
[TBL] [Abstract][Full Text] [Related]
20. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
